BioLife Solutions, Inc. (BLFS)

BioLife Solutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.9	95.39	27.9	19.44	69.86	90.4
Short-Term Investments	49.86	9.2	16.29	43.26	-	-
Cash & Short-Term Investments	81.77	104.58	44.18	62.7	69.86	90.4
Cash Growth	139.54%	136.70%	-29.53%	-10.25%	-22.72%	1302.03%
Receivables	10.06	9.17	7.9	33.94	23.22	8.01
Inventory	27.69	29.01	27.16	34.9	28.35	11.6
Prepaid Expenses	5.92	6	4.67	6.88	4.66	4.65
Restricted Cash	-	-	-	0.03	0.01	0.05
Other Current Assets	-	-	36.69	-	-	-
Total Current Assets	125.43	148.76	120.6	138.45	126.09	114.71
Property, Plant & Equipment	22.51	22.86	19.48	48.27	46.61	24.52
Long-Term Investments	18.47	5.62	5.62	6.4	4.37	5.87
Goodwill	212.3	212.3	212.3	224.74	224.74	58.45
Other Intangible Assets	8.15	9.56	12	32.09	152.15	31.05
Other Long-Term Assets	0.38	0.38	42.71	0.28	0.33	0.23
Total Assets	387.24	399.49	412.71	450.23	554.29	234.83
Accounts Payable	3.21	3.57	2.27	15.37	14.95	3.67
Accrued Expenses	12.72	16.6	13.22	12.36	8.6	3.37
Current Portion of Long-Term Debt	10.05	10.94	6.29	1.81	0.86	0.61
Current Portion of Leases	2.17	1.51	1.29	3.02	2.91	1.12
Current Income Taxes Payable	-	-	0.26	0.98	0.03	0.11
Current Unearned Revenue	0.16	0.1	0.04	0.55	0.81	0.93
Other Current Liabilities	-	-	18.82	10.5	14.55	5.76
Total Current Liabilities	28.31	32.73	42.18	44.58	42.7	15.57
Long-Term Debt	-	5	17.56	23.79	6.35	0.66
Long-Term Leases	11.6	12.72	8.7	15.09	16.76	8.77
Long-Term Deferred Tax Liabilities	0.18	0.12	0.11	0.25	5.49	-
Other Long-Term Liabilities	-	-	6.5	2.33	4.94	4.59
Total Liabilities	40.09	50.58	75.05	86.04	76.24	29.58
Common Stock	0.05	0.05	0.05	0.04	0.04	0.03
Additional Paid-In Capital	698.42	683.94	652.88	611.74	585.4	302.6
Retained Earnings	-351.39	-335.1	-314.92	-246.92	-107.11	-97.39
Comprehensive Income & Other	0.07	0.02	-0.35	-0.68	-0.28	-
Total Common Equity	347.16	348.91	337.66	364.19	478.05	205.25
Shareholders' Equity	347.16	348.91	337.66	364.19	478.05	205.25
Total Liabilities & Equity	387.24	399.49	412.71	450.23	554.29	234.83
Total Debt	23.82	30.17	33.83	43.71	26.88	11.15
Net Cash (Debt)	76.42	79.04	10.91	18.99	42.98	79.25
Net Cash Growth	-	624.79%	-42.57%	-55.82%	-45.77%	1459.73%
Net Cash Per Share	1.63	1.72	0.25	0.44	1.12	2.90
Filing Date Shares Outstanding	47.91	47	45.3	43.21	42.09	33.4
Total Common Shares Outstanding	47.85	46.91	45.17	42.83	41.82	33.04
Working Capital	97.12	116.03	78.43	93.87	83.39	99.14
Book Value Per Share	7.26	7.44	7.48	8.50	11.43	6.21
Tangible Book Value	126.7	127.05	113.36	107.36	101.16	115.75
Tangible Book Value Per Share	2.65	2.71	2.51	2.51	2.42	3.50
Machinery	13.94	13.88	13.8	30.14	24.18	14.15
Construction In Progress	6.56	5.58	5.16	6.75	4.42	2.54
Leasehold Improvements	3.59	3.53	3.5	5.25	3.84	2.39

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q